Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2019 16:30 ET | Source: Neuronetics

Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference

MALVERN, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the...
May 07, 2019 07:30 ET | Source: Neuronetics

Neuronetics Reports First Quarter 2019 Financial and Operating Results

MALVERN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
April 23, 2019 08:00 ET | Source: Neuronetics

Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call

MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
March 27, 2019 16:15 ET | Source: Neuronetics

NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan

MALVERN, Pa., March 27, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
March 26, 2019 08:00 ET | Source: Neuronetics

Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference

MALVERN, Pa., March 26, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
March 05, 2019 07:00 ET | Source: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

MALVERN, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
February 19, 2019 16:15 ET | Source: Neuronetics

Neuronetics to Report Fourth Quarter and Fiscal Year 2018 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
February 15, 2019 08:00 ET | Source: Neuronetics

Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors

MALVERN, Pa., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
January 07, 2019 08:00 ET | Source: Neuronetics

Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue

Preliminary full year 2018 total revenue of approximately $52.8 million, an increase of approximately 31% over the full year 2017, exceeding previously issued guidance MALVERN, Pa., Jan. 07, 2019 ...
November 15, 2018 08:00 ET | Source: Neuronetics

Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference

MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...